3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hodgkin Disease
24
Lymphoma
18
Testicular Neoplasms
4
Teratoma
3
Recurrence
3
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
HIV Infections
3
Vulvar Neoplasms
2
Testicular Germ Cell Tumor
2
Seminoma
2
Neoplasms, Germ Cell and Embryonal
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Head and Neck Neoplasms
2
Endodermal Sinus Tumor
2
Dendritic Cell Sarcoma, Interdigitating
2
Carcinoma, Embryonal
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Waldenstrom Macroglobulinemia
1
Ulcer
1
Squamous Cell Carcinoma of Head and Neck
1
Sertoli-Leydig Cell Tumor
1
Sarcoma, Kaposi
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Processes
1
Ovarian gynandroblastoma
1
Interventions
Oxaliplatin
146
Fluorouracil
137
Capecitabine
121
Leucovorin
106
Irinotecan
85
Radiotherapy
66
Bevacizumab
64
Cetuximab
46
Folfox protocol
27
Surgical Procedures, Operative
23
Radiation
23
Drug Therapy
22
Panitumumab
19
XELOX
18
Chemotherapy, Adjuvant
15
Neoadjuvant Therapy
14
Radiotherapy, Intensity-Modulated
13
Chemoradiotherapy
13
Magnetic Resonance Spectroscopy
11
regorafenib
10
Nivolumab
10
Floxuridine
10
sintilimab
8
raltitrexed
8
Specimen Handling
8
IFL protocol
8
Celecoxib
8
Biopsy
8
trifluridine tipiracil drug combination
7
tislelizumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Rectal Neoplasms
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled